home / stock / knsa / knsa news


KNSA News and Press, Kiniksa Pharmaceuticals Ltd.

Stock Information

Company Name: Kiniksa Pharmaceuticals Ltd.
Stock Symbol: KNSA
Market: NASDAQ

Menu

KNSA KNSA Quote KNSA Short KNSA News KNSA Articles KNSA Message Board
Get KNSA Alerts

News, Short Squeeze, Breakout and More Instantly...

KNSA - Kiniksa Pharmaceuticals files for $400M mixed shelf

2024-06-28 18:21:11 ET More on Kiniksa Pharmaceuticals Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape Kiniksa Pharmaceuticals Q1 2024 Earnings Call Transcript Kiniksa Pharmaceuticals 2024 Q1 - Results - Earnings Call Presentation ...

KNSA - Small-cap, buy-rated stocks with positive estimate revision factors - BofA

2024-06-25 14:07:48 ET More on iShares Russell 2000 ETF: IWM: Small Caps Look Unattractive With Deteriorating Earnings Outlook IWM: Favor Small Caps Over The Technology Sector IWM: Not The Economy For Underdogs (Rating Downgrade) Gap between growth and small-...

KNSA - Kiniksa Pharmaceuticals Partners with NHL Hall-of-Famer Henrik Lundqvist to Raise Awareness of Recurrent Pericarditis

– Campaign to elevate experiences from the recurrent pericarditis community and provide resources to patients and caregivers – HAMILTON, Bermuda, June 24, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceu...

KNSA - Kiniksa Pharmaceuticals Sponsors American Heart Association's Addressing Recurrent Pericarditis Initiative

– Initiative aimed at improving access and outcomes for patients with recurrent pericarditis – – American Heart Association to work with champions at 15 healthcare sites to implement initiative activities and improve care quality – ...

KNSA - (KNSA) Trading Signals

2024-06-12 22:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

KNSA - Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference

HAMILTON, Bermuda, June 04, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Goldman Sachs 45 th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 8:40 a.m. Eastern Time. A...

KNSA - Sector Spotlight: Orphan Drug Developers With Significant Upside

(NewsDirect) The biotech sector is finally beginning to recover following a two year stretch of underperformance that was largely driven by rising interest rates and other macro factors. Biotech has a track record of strong recoveries, with the sector typically seeing double-digit gains after...

KNSA - (KNSA) Long Term Investment Analysis

2024-05-22 07:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

KNSA - Objective long/short (KNSA) Report

2024-05-12 07:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

KNSA - Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference

HAMILTON, Bermuda, May 07, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024 at 10:40 a.m. Pacific Time (1:40 p.m. East...

Next 10